$SRZN Income Statement | Understand Stock

$SRZN

$29.53 +$2.25 (8.25%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Collaboration and license revenue
Research service revenue
Total revenue
Operating expenses:
Research and development
General and administrative
Restructuring
Total operating expenses
Loss from operations
Interest income
Loss on issuance of common stock, pre-funded warrants and warrants
Loss on issuance of common stock, pre-funded warrants and warrants in the 2024 PIPE
Loss on amendment and cancellation of warrants
Loss on execution of the 2025 PIPE
Loss on change in fair value of tranche liability
Other expense, net
Net loss and comprehensive loss
Unrealized gain on marketable securities, net of tax
Comprehensive loss
Net loss per share attributable to common stockholders, basic and diluted
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted
Net loss per share attributable to common stockholders, basic
Net loss per share attributable to common Stockholders, diluted
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted

Comments